Prognostic role of flow-mediated dilation and cardiac risk factors in post-menopausal women.

[1]  T. Rabelink,et al.  Endothelial function and dysfunction: testing and clinical relevance. , 2007, Circulation.

[2]  D. Labarthe,et al.  Taking the Initiative: Implementing the American Heart Association Guide for Improving Cardiovascular Health at the Community Level Healthy People 2010 Heart Disease and Stroke Partnership Community Guideline Implementation and Best Practices Workgroup , 2005, Circulation.

[3]  P. Serruys,et al.  The role of shear stress in the generation of rupture-prone vulnerable plaques , 2005, Nature Clinical Practice Cardiovascular Medicine.

[4]  M. G. Modena,et al.  Flow-mediated vasodilation and the risk of developing hypertension in healthy postmenopausal women. , 2004, Journal of the American College of Cardiology.

[5]  R. Blumenthal,et al.  A practical and evidence-based approach to cardiovascular disease risk reduction. , 2004, Archives of internal medicine.

[6]  S. Nagueh,et al.  Avoiding Papillary Muscle Infarction With Myocardial Contrast Echocardiographic Guidance of Nonsurgical Septal Reduction Therapy for Hypertrophic Obstructive Cardiomyopathy , 2004 .

[7]  A. Selwyn,et al.  Endothelial function, inflammation, and prognosis in cardiovascular disease. , 2003, The American journal of medicine.

[8]  S. Verma,et al.  Endothelial function testing as a biomarker of vascular disease. , 2003, Circulation.

[9]  Antonio Colombo,et al.  From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II. , 2003, Circulation.

[10]  E. Boerwinkle,et al.  From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. , 2003, Circulation.

[11]  J. Keaney,et al.  The clinical implications of endothelial dysfunction. , 2003, Journal of the American College of Cardiology.

[12]  R. Karas,et al.  Clinical Utility of Endothelial Function Testing: Ready for Prime Time? , 2003, Circulation.

[13]  R. Vogel.  Heads and hearts: the endothelial connection. , 2003, Circulation.

[14]  M. Barton,et al.  Endothelial therapy of atherosclerosis and its risk factors. , 2003, Current vascular pharmacology.

[15]  E. Arias,et al.  Deaths: preliminary data for 2001. , 2003, National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System.

[16]  Amir Lerman,et al.  Endothelial Dysfunction: A Marker of Atherosclerotic Risk , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[17]  J Michael Gaziano,et al.  Reducing the global burden of cardiovascular disease: the role of risk factors. , 2002, Preventive cardiology.

[18]  F. Coppi,et al.  Prognostic role of reversible endothelial dysfunction in hypertensive postmenopausal women. , 2002, Journal of the American College of Cardiology.

[19]  M. Davies,et al.  Relationship Between Coronary Artery Remodeling and Plaque Vulnerability , 2002, Circulation.

[20]  T. Pearson.  New Tools for Coronary Risk Assessment: What Are Their Advantages and Limitations? , 2002, Circulation.

[21]  G. Assmann,et al.  Simple Scoring Scheme for Calculating the Risk of Acute Coronary Events Based on the 10-Year Follow-Up of the Prospective Cardiovascular Münster (PROCAM) Study , 2002, Circulation.

[22]  R. Beaglehole,et al.  The real contribution of the major risk factors to the coronary epidemics: time to end the "only-50%" myth. , 2001, Archives of internal medicine.

[23]  S. Yusuf,et al.  Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. , 2001, Circulation.

[24]  S M Grundy,et al.  Improving coronary heart disease risk assessment in asymptomatic people: role of traditional risk factors and noninvasive cardiovascular tests. , 2001, Circulation.

[25]  Joint British recommendations on prevention of coronary heart disease in clinical practice: summary , 2001, BMJ : British Medical Journal.

[26]  R. Virmani,et al.  Coronary atherosclerosis in unheralded sudden coronary death under age 50: histo-pathologic comparison with 'healthy' subjects dying out of hospital. , 2001, Atherosclerosis.

[27]  G. Ford,et al.  Effects of the menopause, gender, and estrogen replacement therapy on vascular nitric oxide activity. , 2000, The Journal of clinical endocrinology and metabolism.

[28]  V. Fuster,et al.  Prevention Conference V: Beyond secondary prevention: identifying the high-risk patient for primary prevention: noninvasive tests of atherosclerotic burden: Writing Group III. , 2000, Circulation.

[29]  K. Williams,et al.  Atherosclerosis--an inflammatory disease. , 1999, The New England journal of medicine.

[30]  D. Levy,et al.  Prediction of coronary heart disease using risk factor categories. , 1998, Circulation.

[31]  E. Braunwald.  Shattuck lecture--cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. , 1997, The New England journal of medicine.

[32]  R. Virmani,et al.  Coronary plaque erosion without rupture into a lipid core. A frequent cause of coronary thrombosis in sudden coronary death. , 1996, Circulation.

[33]  A. Yeung,et al.  Close relation of endothelial function in the human coronary and peripheral circulations. , 1995, Journal of the American College of Cardiology.

[34]  D. Spiegelhalter,et al.  Non-invasive measurement of human endothelium dependent arterial responses: accuracy and reproducibility. , 1995, British heart journal.

[35]  J. K. Lloyd,et al.  Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis , 1992, The Lancet.

[36]  N. Key.  Scratching the surface: endothelium as a regulator of thrombosis, fibrinolysis, and inflammation. , 1992, The Journal of laboratory and clinical medicine.

[37]  J. Sixma,et al.  Nitric Oxide Functions as an Inhibitor of Platelet Adhesion Under Flow Conditions , 1992, Circulation.

[38]  M. N. Tkachenko,et al.  On the mechanism of the involvement of endothelium in reactive hyperemia , 1991, Experientia.

[39]  M. N. Tkachenko,et al.  Mechanisms of involvement of the endothelium in reactive hyperemia , 1990, Bulletin of Experimental Biology and Medicine.

[40]  D. Levy,et al.  Cholesterol and mortality. 30 years of follow-up from the Framingham study. , 1987, JAMA.

[41]  P. Vanhoutte,et al.  Flow-induced release of endothelium-derived relaxing factor. , 1986, The American journal of physiology.

[42]  R F Heller,et al.  How well can we predict coronary heart disease? Findings in the United Kingdom Heart Disease Prevention Project. , 1984, British medical journal.

[43]  L. Ignarro,et al.  Evidence for the inhibitory role of guanosine 3', 5'-monophosphate in ADP-induced human platelet aggregation in the presence of nitric oxide and related vasodilators. , 1981, Blood.

[44]  N. Unwin,et al.  Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Detection, Evaluation, and Treatment of High Blood Cholesterol Education Program (NCEP) Expert Panel on Executive Summary of the Third Report of the National , 2009 .

[45]  Gian Paolo Rossi,et al.  Endothelial function and dysfunction. Part II: Association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension. , 2005, Journal of hypertension.

[46]  Burkhard Hornig,et al.  Endothelial function: a critical determinant in atherosclerosis? , 2004, Circulation.

[47]  G. Rodgers,et al.  Early noninvasive identification of atherosclerosis: a new paradigm in preventive cardiology. , 2004, The American heart hospital journal.

[48]  Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. , 2002, Circulation.

[49]  J. Neaton,et al.  Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Overall findings and differences by age for 316,099 white men. Multiple Risk Factor Intervention Trial Research Group. , 1992, Archives of internal medicine.

[50]  James D. Neaton,et al.  Serum Cholesterol, Blood Pressure, Cigarette Smoking, and Death From Coronary Heart Disease Overall Findings and Differences by Age for 316099 White Men , 1992 .

[51]  V. Fuster,et al.  The pathogenesis of coronary artery disease and the acute coronary syndromes (1). , 1992, The New England journal of medicine.